Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $38.2700 (2.38%) ($36.9100 - $38.4900) on Tue. Nov. 10, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3% (three month average) | RSI | 75 | Latest Price | $38.2700(2.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 3.9% a day on average for past five trading days. | Weekly Trend | HALO advances 9.7% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(48%) IWM(47%) IWC(44%) ARKG(41%) | Factors Impacting HALO price | HALO will decline at least -1.5% in a week (0% probabilities). VIXM(-31%) UUP(-14%) VXX(-13%) EDOC(-6%) TLT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.5% (StdDev 3%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $35.83(6.81%) | 10 Day Moving Average | $32.72(16.96%) | 20 Day Moving Average | $31.31(22.23%) | To recent high | 0% | To recent low | 48.7% | Market Cap | $5.23b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |